0001012975-24-000230.txt : 20240515
0001012975-24-000230.hdr.sgml : 20240515
20240515163246
ACCESSION NUMBER: 0001012975-24-000230
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240515
DATE AS OF CHANGE: 20240515
EFFECTIVENESS DATE: 20240515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARCH Venture Management, LLC
CENTRAL INDEX KEY: 0001274403
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-19358
FILM NUMBER: 24951791
BUSINESS ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
BUSINESS PHONE: 7733806600
MAIL ADDRESS:
STREET 1: C/O ARCH VENTURE PARTNERS
STREET 2: 8755 W. HIGGINS RD. #1025
CITY: CHICAGO
STATE: IL
ZIP: 60631
FORMER COMPANY:
FORMER CONFORMED NAME: ARCH VENTURE CORP
DATE OF NAME CHANGE: 20031224
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001274403
XXXXXXXX
03-31-2024
03-31-2024
ARCH Venture Management, LLC
C/O ARCH VENTURE PARTNERS
8755 W. HIGGINS RD. #1025
CHICAGO
IL
60631
13F HOLDINGS REPORT
028-19358
000158196
802-75688
N
Mark McDonnell
Managing Director, CFO and CAO
773-380-6600
/s/ Mark McDonnell
Chicago
IL
05-15-2024
0
8
80276945
false
INFORMATION TABLE
2
ARCH.xml
UNITY BIOTECHNOLOGY, INC.
COM
91381U200
1647900
1004817
SH
SOLE
0
0
1004817
DENALI THERAPEUTICS, INC.
COM
24823R105
7823229
381249
SH
SOLE
0
0
381249
Q32 BIO INC.
COM
746964105
5461013
320482
SH
SOLE
0
0
320482
GOSSAMER BIO, INC.
COM
38341P102
9505981
8055916
SH
SOLE
0
0
8055916
SINGULAR GENOMICS SYSTEMS, INC.
COM
82933R100
1953408
3798926
SH
SOLE
0
0
3798926
CERO THERAPEUTICS HOLDINGS, INC.
CLASS A COM
71902K105
4433989
1444296
SH
SOLE
0
0
1444296
ERASCA, INC.
COM
29479A108
22774441
11055554
SH
SOLE
0
0
11055554
VERVE THERAPEUTICS, INC.
COM
92539P101
26676984
2008809
SH
SOLE
0
0
2008809